Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis.
Takashima H, Ohnuki K, Manabe S, Koga Y, Tsumura R, Anzai T, Wang Y, Yin X, Sato N, Shigekawa Y, Nambu A, Usuda S, Haba H, Fujii H, Yasunaga M.
Takashima H, et al. Among authors: yin x.
Mol Pharm. 2023 Feb 6;20(2):1156-1167. doi: 10.1021/acs.molpharmaceut.2c00869. Epub 2022 Dec 27.
Mol Pharm. 2023.
PMID: 36573995
Free PMC article.